IGF1R and breast cancer: Although there is a strong evidence of the anti-tumorogenic properties of CNR2 agonists, not much is known about the role of CNR2 activation on different growth factor receptor, such as epidermal growth factor receptor (EGFR) and insulin-like growth factor 1 receptor (IGF-IR)-mediated tumorigenic events in breast cancer.